PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22116304-7	2012	Immunoblot assays indicated that hypoxia and L-mimosine stabilized hypoxia-inducible factor-1alpha (HIF-1alpha) and induced Btg2 and Ndrg1 protein expression, but downregulated protein levels of cyclin A in both PC-3 and LNCaP cells.	Mimosine	45-55	cyclin A2	Homo sapiens	195-203	
7628532-8	1995	For example, treatment with mimosine, which arrests cells in G1 with 2C DNA, resulted in cyclin A accumulating to mitotic levels, whereas cyclin B remained at a low concentration, the first time this phenomenon has been observed.	Mimosine	28-36	cyclin A2	Homo sapiens	89-97	
8502485-5	1993	Pharmacological blockade with mimosine was utilized to further delineate cyclin A expression and to distinguish the temporal induction from the mechanisms of enzyme activation.	Mimosine	30-38	cyclin A2	Homo sapiens	73-81	
1386764-4	1992	Furthermore, cells synchronized in late G1 by exposure to the drug mimosine contain active cyclin A/p34 CDC2 kinase, indicating that p34 CDC2 activation can occur before DNA synthesis begins.	Mimosine	67-75	cyclin A2	Homo sapiens	91-99	
8940249-5	1996	After release from mimosine treatment, 84% of the cell population remained in G1 up to 8 h. Treating breast cancer cells with 400 microM mimosine for 24 h inhibited cyclin E- and cyclin A-associated kinase activity by 85% or more, although immunoblots using anti-cyclin A, cyclin E, cdc2, and cdk2 antibodies showed that these key subunits were still present in the cells at pretreatment levels.	Mimosine	137-145	cyclin A2	Homo sapiens	179-187	
8940249-5	1996	After release from mimosine treatment, 84% of the cell population remained in G1 up to 8 h. Treating breast cancer cells with 400 microM mimosine for 24 h inhibited cyclin E- and cyclin A-associated kinase activity by 85% or more, although immunoblots using anti-cyclin A, cyclin E, cdc2, and cdk2 antibodies showed that these key subunits were still present in the cells at pretreatment levels.	Mimosine	137-145	cyclin A2	Homo sapiens	263-271